Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome

Dravet syndrome (DS) is a monogenic, often refractory, epilepsy resultant from SCN1A haploinsufficiency in humans. A novel therapeutic target in DS that can be engaged in isolation or as adjunctive therapy is highly desirable. Here, we demonstrate reduced expression of the rodent glutamate transport...

Descripción completa

Detalles Bibliográficos
Autores principales: Hameed, Mustafa Q., Hui, Benjamin, Lin, Rui, MacMullin, Paul C., Pascual‐Leone, Andres, Vermudez, Sheryl Anne D., Rotenberg, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502630/
https://www.ncbi.nlm.nih.gov/pubmed/37452008
http://dx.doi.org/10.1002/acn3.51851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502630/
https://www.ncbi.nlm.nih.gov/pubmed/37452008
http://dx.doi.org/10.1002/acn3.51851

Ejemplares similares